Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action (Q36327074)

13 August 2017

1 reference

title

Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action (English)

1 reference

13 August 2017

Gary H Lyman

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Expert Opinion on Biological Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

1635-1646

1 reference

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

The colony-stimulating factors: use to prevent and treat neutropenia and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

The impact of frequent injections for hematopoietic growth factor support on patients receiving chemotherapy: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Open-label, Randomized Study of Pegfilgrastim vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1635

10.1517/14712598.5.12.1635

21 January 2018

Identifiers

DOI

1 reference

release_2a4e2ipkfvbnbixu4olo57ghta

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2a4e2ipkfvbnbixu4olo57ghta

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference